Gaetani L - Search Results

1

Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers.

Barba L, Paolini Paoletti F, Bellomo G, Gaetani L, Halbgebauer S, Oeckl P, Otto M, Parnetti L. Barba L, et al. Among authors: gaetani l. Mov Disord. 2022 Apr;37(4):669-683. doi: 10.1002/mds.28941. Epub 2022 Feb 5. Mov Disord. 2022. PMID: 35122299 Free PMC article. Review.

2

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.

Gaetani L, Höglund K, Parnetti L, Pujol-Calderon F, Becker B, Eusebi P, Sarchielli P, Calabresi P, Di Filippo M, Zetterberg H, Blennow K. Gaetani L, et al. Alzheimers Res Ther. 2018 Jan 23;10(1):8. doi: 10.1186/s13195-018-0339-1. Alzheimers Res Ther. 2018. PMID: 29370869 Free PMC article.

3

Neurofilament light chain as a biomarker in neurological disorders.

Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Gaetani L, et al. J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870-881. doi: 10.1136/jnnp-2018-320106. Epub 2019 Apr 9. J Neurol Neurosurg Psychiatry. 2019. PMID: 30967444 Review.

4

CSF and blood biomarkers for Parkinson's disease.

Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P. Parnetti L, et al. Among authors: gaetani l. Lancet Neurol. 2019 Jun;18(6):573-586. doi: 10.1016/S1474-4422(19)30024-9. Epub 2019 Apr 10. Lancet Neurol. 2019. PMID: 30981640 Review.

5

Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.

Gaetani L, Salvadori N, Lisetti V, Eusebi P, Mancini A, Gentili L, Borrelli A, Portaccio E, Sarchielli P, Blennow K, Zetterberg H, Parnetti L, Calabresi P, Di Filippo M. Gaetani L, et al. J Neurol. 2019 Sep;266(9):2157-2163. doi: 10.1007/s00415-019-09398-7. Epub 2019 May 25. J Neurol. 2019. PMID: 31129709

6

Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.

Gaetani L, Eusebi P, Mancini A, Gentili L, Borrelli A, Parnetti L, Calabresi P, Sarchielli P, Blennow K, Zetterberg H, Di Filippo M. Gaetani L, et al. Mult Scler Relat Disord. 2019 Oct;35:228-232. doi: 10.1016/j.msard.2019.07.025. Epub 2019 Jul 27. Mult Scler Relat Disord. 2019. PMID: 31404762

7

Serum neurofilament light chain as a preclinical marker of neurodegeneration.

Parnetti L, Gaetani L, Di Filippo M. Parnetti L, et al. Among authors: gaetani l. Lancet Neurol. 2019 Dec;18(12):1070-1071. doi: 10.1016/S1474-4422(19)30405-3. Lancet Neurol. 2019. PMID: 31701888 No abstract available.

8

The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers.

Paolini Paoletti F, Gaetani L, Parnetti L. Paolini Paoletti F, et al. Among authors: gaetani l. Biomolecules. 2020 Feb 19;10(2):335. doi: 10.3390/biom10020335. Biomolecules. 2020. PMID: 32092971 Free PMC article. Review.

9

Molecular profiling in Parkinsonian syndromes: CSF biomarkers.

Paolini Paoletti F, Gaetani L, Parnetti L. Paolini Paoletti F, et al. Among authors: gaetani l. Clin Chim Acta. 2020 Jul;506:55-66. doi: 10.1016/j.cca.2020.03.002. Epub 2020 Mar 4. Clin Chim Acta. 2020. PMID: 32142717 Review.

10

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers.

Gaetani L, Salvadori N, Chipi E, Gentili L, Borrelli A, Parnetti L, Di Filippo M. Gaetani L, et al. Neural Regen Res. 2021 Jan;16(1):36-42. doi: 10.4103/1673-5374.286949. Neural Regen Res. 2021. PMID: 32788445 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page